# ESSA Pharma Inc.

ESSA Pharma Inc. is a company headquartered in Vancouver, British Columbia, Canada.

## Company overview

- **Legal name:** ESSA Pharma Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Vancouver, British Columbia, Canada
- **Incorporated in:** A1
- **Fiscal year end:** September 30
- **SEC CIK:** 0001633932

## About

ESSA Pharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001633932, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-12-17, it reported net income of USD -28,542,821; total assets of USD 128,112,003 for the fiscal period ended 2024-09-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-09-30)

- **Net income:** -$28.5M (USD -28,542,821)
- **Total assets:** $128.1M (USD 128,112,003)
- **Cash and equivalents:** $103.7M (USD 103,709,537)
- **Operating cash flow:** -$22.7M (USD -22,716,199)

### FY2023 (period ended 2023-09-30)

- **Net income:** -$26.6M (USD -26,582,343)
- **Total assets:** $149.1M (USD 149,122,131)
- **Cash and equivalents:** $33.7M (USD 33,701,912)
- **Operating cash flow:** -$19.8M (USD -19,781,716)

### FY2022 (period ended 2022-09-30)

- **Net income:** -$35.1M (USD -35,103,251)
- **Total assets:** $169.5M (USD 169,505,295)
- **Cash and equivalents:** $57.1M (USD 57,076,475)
- **Operating cash flow:** -$28.7M (USD -28,704,169)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2021 (period ended 2021-09-30)

- **Net income:** -$36.8M (USD -36,805,461)
- **Total assets:** $198.2M (USD 198,165,818)
- **Cash and equivalents:** $137.8M (USD 137,825,024)
- **Operating cash flow:** -$25.4M (USD -25,415,611)

## Recent SEC filings

- Form 8-K — filed 2025-10-09 — period 2025-10-09 — FORM 8-K
- Form 8-K — filed 2025-10-06 — period 2025-10-03 — FORM 8-K
- Form 8-K — filed 2025-10-03 — period 2025-09-30 — FORM 8-K
- Form 8-K — filed 2025-09-30 — period 2025-09-30 — FORM 8-K
- Form 8-K — filed 2025-09-24 — period 2025-09-23 — FORM 8-K
- Form 8-K — filed 2025-09-10 — period 2025-09-10 — FORM 8-K
- Form 8-K — filed 2025-08-25 — period 2025-08-25 — FORM 8-K
- Form 8-K — filed 2025-08-14 — period 2025-08-13 — FORM 8-K
- Form 10-Q — filed 2025-08-13 — period 2025-06-30 — 10-Q
- Form 8-K — filed 2025-08-06 — period 2025-08-05 — FORM 8-K
- Form 8-K — filed 2025-07-31 — period 2025-07-31 — FORM 8-K
- Form 8-K — filed 2025-07-23 — period 2025-07-23 — FORM 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/essa-pharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology